In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 5, 2007, Pages 1961-1964

  Calzada, Catherine ^a   Coulon, Laurent ^b   Halimi, Déborah ^b   Le Coquil, Elodie ^b   Pruneta Deloche, Valérie ^b   Moulin, Philippe ^b   Ponsin, Gabriel ^b   Véricel, Evelyne ^b   Lagarde, Michel ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2; THROMBOXANE B2; GLYCOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GLYCATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PRIORITY JOURNAL; PROTEIN ISOLATION; THROMBOCYTE ACTIVATION; BLOOD; DRUG EFFECT; ENZYMOLOGY; GLUCOSE BLOOD LEVEL; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PHOSPHORYLATION; PHYSIOLOGY; THROMBOCYTE;

BLOOD GLUCOSE; BLOOD PLATELETS; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATION-REDUCTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLATELET ACTIVATION; THROMBOXANE B2;

EID: 34249856992     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2045     Document Type: Article

References (20)

1. De Cristofaro R, Rocca B, Vitacolonna E, Falco A, Marchesani P, Ciabattoni G, Landolfi R, Patrono C, Davi G 2003 Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. J Thromb Haemost 1:250-256
2. Véricel E, Januel C, Carreras M, Moulin P, Lagarde M 2004 Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Diabetes 53:1046-1051
3. Hunt JV, Smith CC, Wolff SP 1990 Autooxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39:1420-1424
4. Havel RJ, Eder HA, Bragdon JH 1955 The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353
5. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
6. Véricel E, Croset M, Sedivy P, Courpron PH, Dechavanne M, Lagarde M 1988 Platelets and aging. I. Aggregation, arachidonate metabolism and antioxidant status. Thromb Res 49:331-342
7. Therasse J, Lemonnier F 1987 Determination of plasma lipoperoxides by high-performance liquid chromatography. J Chromatogr 413:237-241
8. Duell PB, Oram JF, Bierman EL 1990 Nonenzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts. Diabetes 39:1257-1263
9. Lagarde M, Bryon PA, Guichardant M, Dechavanne M 1980 A simple and efficient method for platelet isolation from their plasma. Thromb Res 17:581-588
10. Coulon L, Calzada C, Moulin P, Véricel E, Lagarde M 2003 Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets. Free Radic Biol Med 35:616-625
11. Meraji S, Moore CE, Skinner O, Bruckdorfer KR 1992 The importance of oxidation or glycosylation of low-density lipoproteins in relation to platelet activation. Platelets 3:155-162
12. Weidtmann A, Scheithe R, Hrboticky N, Pietsch A, Lorenz R, Siess W 1995 Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2. Arterioscler Thromb Vasc Biol 15:1131-1138
13. Hackeng CM, Relou IA, Pladet MW, Gorter G, van Rijn HJ, Akkerman JW 1999 Early platelet activation by low density lipoprotein via p38MAP kinase. Thromb Haemost 82:1749-1756
14. Knott HM, Brown BE, Davies MJ, Dean RT 2003 Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles. Eur J Biochem 270:3572-3582
15. Ferretti G, Rabini RA, Bacchetti T, Vignini A, Salvolini E, Ravaglia F, Curatola G, Mazzanti L 2002 Glycated low density lipoproteins modify platelet properties: a compositional and functional study. J Clin Endocrinol Metab 87:2180-2184
16. Relou IA, Hackeng CM, Akkerman JW, Malle E 2003 Low-density lipoprotein and its effect on human blood platelets. Cell Mol Life Sci 60:961-971
17. Mowri H, Frei B, Keaney JF 2000 Glucose enhancement of LDL oxidation is strictly metal ion dependent. Free Radic Biol Med 29:814-824
18. Watanabe J, Wohltmann HJ, Klein RL, Colwell JA, Lopes-Virella MF 1988 Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients. Diabetes 37:1652-1657
19. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C, Schernthaner G, Mueller MM 1995 Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 98:469-475
20. Jenkins AJ, Thorpe SR, Alderson NL, Hermayer KL, Lyons TJ, King LP, Chassereau CN, Klein RL 2004 In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type 1 diabetes. Metabolism 53:969-976